Cargando…
Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables
INTRODUCTION: Today cocaine use is very frequently associated with adolescents with maladaptive personality traits and impulse control disorder. It requires a multidisciplinary approach and individualized treatments to improve the clinic and achieve the abandonment of consumption. OBJECTIVES: 1. To...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528295/ http://dx.doi.org/10.1192/j.eurpsy.2021.618 |
_version_ | 1784801273557549056 |
---|---|
author | Sánchez, S. Pérez Herrero, I. Martín Fernández, M.A. Cutillas Güimil, D. Raya Portero, A. Crespo |
author_facet | Sánchez, S. Pérez Herrero, I. Martín Fernández, M.A. Cutillas Güimil, D. Raya Portero, A. Crespo |
author_sort | Sánchez, S. Pérez |
collection | PubMed |
description | INTRODUCTION: Today cocaine use is very frequently associated with adolescents with maladaptive personality traits and impulse control disorder. It requires a multidisciplinary approach and individualized treatments to improve the clinic and achieve the abandonment of consumption. OBJECTIVES: 1. To assess the efficacy of monthly injectable paliperidone palmitate treatment in controlling impulsivity. 2. Determine the consumption of toxins after treatment. METHODS: Sample: Adolescents, 14-17 years old, with a diagnosis of Personality Limit T and cocaine consumption who start treatment with Paliperidone Palmitate LD IM (50-100mg / month) in monotherapy, with Diazepam 5mg if significant anxiety. Retrospective data collection. Plutchik impulsivity scale (IE) before starting treatment and at 3 months. Statistical analysis SPSS 20.0 RESULTS: Twelve adolescents who met the inclusion criteria were included and 12 adolescents, 83% male, 16% female, completed the questionnaires. After its application and correction through non-parametric tests (N <30), scores in the EI questionnaire of a mean of 37.42 points in the pretest were observed, corresponding to a severe level of impulsivity; and a mean of 26.28 points in the post-test, compatible with a mild-moderate degree of impulsive symptoms. A decrease in the consumption of toxins was observed in 65% of the cases. CONCLUSIONS: In our experience, the management of toxic consumption in adolescent population with severe impulsivity symptoms has great limitations due to the scarce resources available. The Palpitate of Paliperidone long-term treatment has been useful in the approach of serious registered cases, being associated with symptomatic improvement and decrease in consumption. |
format | Online Article Text |
id | pubmed-9528295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95282952022-10-17 Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables Sánchez, S. Pérez Herrero, I. Martín Fernández, M.A. Cutillas Güimil, D. Raya Portero, A. Crespo Eur Psychiatry Abstract INTRODUCTION: Today cocaine use is very frequently associated with adolescents with maladaptive personality traits and impulse control disorder. It requires a multidisciplinary approach and individualized treatments to improve the clinic and achieve the abandonment of consumption. OBJECTIVES: 1. To assess the efficacy of monthly injectable paliperidone palmitate treatment in controlling impulsivity. 2. Determine the consumption of toxins after treatment. METHODS: Sample: Adolescents, 14-17 years old, with a diagnosis of Personality Limit T and cocaine consumption who start treatment with Paliperidone Palmitate LD IM (50-100mg / month) in monotherapy, with Diazepam 5mg if significant anxiety. Retrospective data collection. Plutchik impulsivity scale (IE) before starting treatment and at 3 months. Statistical analysis SPSS 20.0 RESULTS: Twelve adolescents who met the inclusion criteria were included and 12 adolescents, 83% male, 16% female, completed the questionnaires. After its application and correction through non-parametric tests (N <30), scores in the EI questionnaire of a mean of 37.42 points in the pretest were observed, corresponding to a severe level of impulsivity; and a mean of 26.28 points in the post-test, compatible with a mild-moderate degree of impulsive symptoms. A decrease in the consumption of toxins was observed in 65% of the cases. CONCLUSIONS: In our experience, the management of toxic consumption in adolescent population with severe impulsivity symptoms has great limitations due to the scarce resources available. The Palpitate of Paliperidone long-term treatment has been useful in the approach of serious registered cases, being associated with symptomatic improvement and decrease in consumption. Cambridge University Press 2021-08-13 /pmc/articles/PMC9528295/ http://dx.doi.org/10.1192/j.eurpsy.2021.618 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Sánchez, S. Pérez Herrero, I. Martín Fernández, M.A. Cutillas Güimil, D. Raya Portero, A. Crespo Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables |
title | Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables |
title_full | Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables |
title_fullStr | Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables |
title_full_unstemmed | Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables |
title_short | Adolescents and dual pathology. Assessment of treatment with paliperidona palmitato long-term injectables |
title_sort | adolescents and dual pathology. assessment of treatment with paliperidona palmitato long-term injectables |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528295/ http://dx.doi.org/10.1192/j.eurpsy.2021.618 |
work_keys_str_mv | AT sanchezsperez adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables AT herreroimartin adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables AT fernandezmacutillas adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables AT guimildraya adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables AT porteroacrespo adolescentsanddualpathologyassessmentoftreatmentwithpaliperidonapalmitatolongterminjectables |